↓ Skip to main content

Cochrane Database of Systematic Reviews

Aripiprazole versus typical antipsychotic drugs for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 tweeters
weibo
1 weibo user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
188 Mendeley
Title
Aripiprazole versus typical antipsychotic drugs for schizophrenia
Published in
Cochrane database of systematic reviews, July 2008
DOI 10.1002/14651858.cd006617.pub3
Pubmed ID
Authors

Jayanti Bhattacharjee, Hany G El-Sayeh

Abstract

Aripiprazole is a relatively new antipsychotic drug, said to be the prototype of a new third generation of antipsychotics; the so-called dopamine-serotonin system stabilisers. In this review we examine how the efficacy and tolerability of aripiprazole differs from that of typical antipsychotics.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 188 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 1%
Unknown 186 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 14%
Researcher 26 14%
Student > Bachelor 26 14%
Student > Doctoral Student 18 10%
Student > Postgraduate 13 7%
Other 42 22%
Unknown 36 19%
Readers by discipline Count As %
Medicine and Dentistry 67 36%
Psychology 23 12%
Nursing and Health Professions 15 8%
Neuroscience 8 4%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Other 27 14%
Unknown 40 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2017.
All research outputs
#3,778,980
of 19,096,926 outputs
Outputs from Cochrane database of systematic reviews
#6,379
of 11,929 outputs
Outputs of similar age
#63,173
of 329,941 outputs
Outputs of similar age from Cochrane database of systematic reviews
#150
of 245 outputs
Altmetric has tracked 19,096,926 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,929 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.0. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 329,941 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 245 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.